For $125 per share in money.

As a result of the merger planned to be effected later today, all remaining eligible Onyx shares will be changed into the right to receive $125 per share in cash, without interest and less any relevant withholding taxes, the same price that was paid in the tender present . Pursuing completion of the merger, Onyx shares will cease to be exchanged on the NASDAQ Global Market, later on today which is expected to take effect. About Amgen Amgen is committed to unlocking the potential of biology for sufferers suffering from serious ailments by discovering, developing, developing and providing innovative human therapeutics. This approach begins through the use of tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human being biology.The FDA established the Fast Track designation process to facilitate the advancement and expedite the overview of drugs intended to treat significant or life-threatening circumstances and that demonstrate the potential to address unmet medical requirements. Fast Track designation facilitates meetings with FDA to go over all areas of development to aid approval. It also provides the chance to submit parts of a New Drug Application on a rolling basis, where FDA may review portions of the NDA because they are received instead of waiting for the entire NDA submission. Furthermore, an easy Track designated product could be qualified to receive priority review if backed by clinical data during NDA submission.

Other entries from category "reports":

Random entries